Sarepta Therapeutics, Inc. SRPT Free cash flow margin
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from Sarepta Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed November 6, 2025, on SEC EDGAR. View the filing →
Ask your AI about Sarepta Therapeutics, Inc.'s free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sarepta Therapeutics, Inc.'s free cash flow margin?
- Sarepta Therapeutics, Inc. (SRPT) reported free cash flow margin of -28.7% in Q3 2024.
- How has Sarepta Therapeutics, Inc.'s free cash flow margin changed year-over-year?
- Sarepta Therapeutics, Inc.'s free cash flow margin increased by 47.5% year-over-year, from -54.6% to -28.7%.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s free cash flow margin?
- Over 2 years (2021 to 2023), Sarepta Therapeutics, Inc.'s free cash flow margin has grown at a -17.8% compound annual growth rate (CAGR), from -68.6% to -46.4%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.